A 2023 Agenda for Substance Use Prevention and Treatment in the US
JAMA · 2023
DOI: 10.1001/jama.2023.1090 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Rahul Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: White House Office of National Drug Control Policy, Washington, DC. Hauptthemen laut MEDLINE: Substance-Related Disorders, Health Policy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
In this Viewpoint, officials from the White House Office of National Drug Control Policy describe 3 actions that health care personnel can take to expand prevention and treatment of substance misuse and overdose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- White House Office of National Drug Control Policy, Washington, DC.
Zitieren
APA
Gupta, R., Wright, N. F., & Holtgrave, D. R. (2023). A 2023 Agenda for Substance Use Prevention and Treatment in the US. JAMA. https://doi.org/10.1001/jama.2023.1090
Vancouver
Gupta R, Wright NF, Holtgrave DR. A 2023 Agenda for Substance Use Prevention and Treatment in the US. JAMA. 2023. doi:10.1001/jama.2023.1090
BibTeX
@article{Gupta2023,
author = {Gupta, Rahul and Wright, Nicholas F and Holtgrave, David R},
title = {A 2023 Agenda for Substance Use Prevention and Treatment in the US},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.1090}
}
EUVIMED